- Home
- WLY vs OCUL Comparison
WLY vs OCUL Comparison
Compare WLY & OCUL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WLY
- OCUL
- Stock Information
- Founded
- WLY 1807
- OCUL 2006
- Country
- WLY United States
- OCUL United States
- Employees
- WLY N/A
- OCUL N/A
- Industry
- WLY Books
- OCUL Biotechnology: Pharmaceutical Preparations
- Sector
- WLY Consumer Discretionary
- OCUL Health Care
- Exchange
- WLY Nasdaq
- OCUL Nasdaq
- Market Cap
- WLY 2.2B
- OCUL 2.3B
- IPO Year
- WLY N/A
- OCUL 2014
- Fundamental
- Price
- WLY $36.36
- OCUL $10.69
- Analyst Decision
- WLY
- OCUL Strong Buy
- Analyst Count
- WLY 0
- OCUL 10
- Target Price
- WLY N/A
- OCUL $22.33
- AVG Volume (30 Days)
- WLY 387.1K
- OCUL 2.4M
- Earning Date
- WLY 12-04-2025
- OCUL 11-04-2025
- Dividend Yield
- WLY 3.86%
- OCUL N/A
- EPS Growth
- WLY N/A
- OCUL N/A
- EPS
- WLY 1.78
- OCUL N/A
- Revenue
- WLY $1,670,600,000.00
- OCUL $55,783,000.00
- Revenue This Year
- WLY $0.86
- OCUL N/A
- Revenue Next Year
- WLY $2.66
- OCUL $17.75
- P/E Ratio
- WLY $20.70
- OCUL N/A
- Revenue Growth
- WLY N/A
- OCUL N/A
- 52 Week Low
- WLY $35.94
- OCUL $5.79
- 52 Week High
- WLY $53.96
- OCUL $13.85
- Technical
- Relative Strength Index (RSI)
- WLY 41.89
- OCUL 36.57
- Support Level
- WLY $36.19
- OCUL $10.40
- Resistance Level
- WLY $38.04
- OCUL $12.10
- Average True Range (ATR)
- WLY 1.04
- OCUL 0.45
- MACD
- WLY 0.14
- OCUL -0.09
- Stochastic Oscillator
- WLY 17.57
- OCUL 12.64
About WLY John Wiley & Sons Inc.
John Wiley & Sons Inc is one of the world's greatest publishers and a trusted leader in research and learning. Its industry-principal content, services, platforms, and knowledge networks are tailored to meet the evolving needs of its customers and partners, including researchers, students, instructors, professionals, institutions, and corporations. The company empowers knowledge-seekers to transform today's obstacles into tomorrow's brightest opportunities. For more than two centuries, the company has been delivering on its timeless mission to unlock human potential.
About OCUL Ocular Therapeutix Inc.
Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.